Huppert, Laura A. http://orcid.org/0000-0002-8512-5608
Fisch, Samantha
Tsopurashvili, Elene
Somepalle, Sai Sahitha
Salans, Mia
Vasudevan, Harish N.
Jo Chien, A.
Majure, Melanie
Rugo, Hope S.
Balassanian, Ronald
Boreta, Lauren
Melisko, Michelle E.
Article History
Received: 6 February 2024
Accepted: 10 April 2024
First Online: 18 June 2024
Declarations
:
: Laura A. Huppert: Ad board/honoraria from: AstraZeneca, Pfizer. A. Jo Chien: Research funding to institution: Merck, Puma, Amgen, Seagen. Hope S. Rugo: Research support for clinical trials through the University of California: Pfizer, Merck, Novartis, Lilly, Roche, Daiichi, Seattle Genetics, Macrogenics, Sermonix, Boehringer Ingelheim, AstraZeneca, Astellas and Gilead. Honoraria from: Puma, Samsung, Mylan, Chugai, Blueprint, and NAPO. Ronald Balassanian: Consultant—Genentech; Stockholder—Cerus Corp. Michelle E. Melisko: Research funding to institution: AstraZeneca, Novartis, KCRN Research, Puma, Seattle Genetics. For spouse: Speaker bureau/honoraria: Genentech, Gilead, AstraZeneca. Stock Ownership: Merrimack. Samantha Fisch, Elene Tsopurashvili, Sai Sahitha Somepalle, Mia Salans, Harish Vasudevam, Melanie Majure, Laurena Boreta: No financial disclosures.
: This research was approved by the UCSF Institutional Review Board.
: Patient consent was not required given that this was a retrospective, observational study approved by the UCSF Institutional Review Board.